R 201015Z MAY 21
MSGID/GENADMIN/CMC WASHINGTON DC MRA MP//
SUBJ/UPDATE TO CONDITIONS-BASED APPROACH TO CORONAVIRUS DISEASE 2019 PERSONNEL MOVEMENT AND TRAVEL RESTRICTIONS ALONG WITH THE IMPLEMENTATION OF FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 20)//
REF/E/MSGID/MARADMIN/CMC WASHINGTON DC PPO/R212257APR20//
REF/F/MSGID/MARADMIN/CMC WASHINGTON DC MRA MP/R262107ZAPR20//
REF/G/MSGID/MARADMIN/CMC WASHINGTON DC MRA MM/R052305ZJUN20//
REF/H/MSGID/MARADMIN/CMC WASHINGTON DC MRA MM/R221935ZOCT20//
REF/I/MSGID/MARADMIN/CMC WASHINGTON DC MRA MP/R051543ZFEB21//
REF/Q/MSGID/JOINT TRAVEL REGULATIONS//
REF/T/MSGID/MARADMIN/CMC WASHINGTON DC MRA MP/R231525ZFEB21//
REF/Z/MSGID/MARADMIN/CMC WASHINGTON DC PPO/R022335ZAPR21//
NARR/REF A IS OSD MEMORANDUM, UPDATE TO CONDITIONS-BASED APPROACH TO CORONAVIRUS DISEASE 2019 PERSONNEL MOVEMENT AND TRAVEL RESTRICTIONS. REF B IS SECNAV MEMORANDUM, DEPARTMENT OF THE NAVY IMPLEMENTATION OF TRANSITION TO CONDITIONS-BASED APPROACH TO CORONAVIRUS DISEASE 2019 PERSONNEL MOVEMENT AND TRAVEL RESTRICTIONS. REF C IS USD(PR) MEMORANDUM, FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 20) – DEPARTMENT OF DEFENSE GUIDANCE FOR PERSONNEL TRAVELING DURING THE CORONAVIRUS DISEASE 2019 PANDEMIC. REF D IS ASN(MRA) MEMORANDUM, DEPARTMENT OF THE NAVY GUIDANCE FOR PERSONNEL TRAVELING DURING THE CORONAVIRUS DISEASE 2019 PANDEMIC. REF E IS MARADMIN 254/20, UPDATE 7: U.S. MARINE CORPS DISEASE CONTAINMENT PREPAREDNESS PLANNING GUIDANCE FOR 2019 NOVEL CORONAVIRUS (COVID-19): MODIFICATION AND REISSUANCE OF DOD RESPONSE TO CORONAVIRUS DISEASE 2019-TRAVEL RESTRICTIONS. REF F IS MARADMIN 264/20, UPDATE 1: COVID-19 SUPPLEMENTAL PERSONNEL GUIDANCE. REF G IS MARADMIN 333/20, TRANSITION TO CONDITIONS-BASED PHASED APPROACH TO CORONAVIRUS DISEASE 2019 PERSONNEL MOVEMENT AND TRAVEL RESTRICTIONS UPDATE. REF H IS MARADMIN 636/20, UPDATE TO MARADMIN 333-20 TO INCORPORATE CHANGE TO DELEGATION OF WAIVER APPROVAL AUTHORITY FOR CORONAVIRUS DISEASE 2019 PERSONNEL MOVEMENT AND TRAVEL RESTRICTIONS. REF I IS MARADMIN 059/21, SUPPLEMENTAL MESSAGE TO MARADMIN 333-20 TO INCORPORATE FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 14) DIRECTIONS. REF J IS PAA 04-20, SUPPLEMENTAL GUIDANCE IN THE REPORTING OF COVID-19 PERSONNEL STATUS. REF K IS PAA 07-20, SUPPLEMENTAL GUIDANCE IN THE REPORTING OF COVID-19 PERSONNEL STATUS. REF L IS DIRECTOR, DEFENSE HEALTH AGENCY, MEMORANDUM, SUPPLEMENTAL HEALTH CARE PROGRAM BLANKET WAIVER FOR CORONAVIRUS 2019 (COVID-19) TESTING FOR ASYMPTOMATIC TIER 1-4 ACTIVE DUTY SERVICE MEMBERS. REF M IS DODI 6025.23, HEALTH CARE ELIGIBILITY UNDER THE SECRETARIAL DESIGNEE (SECDES) PROGRAM AND RELATED SPECIAL AUTHORITIES. REF N IS DSD MEMORANDUM, EXEMPTION – STOP MOVEMENT FOR TRAVEL FOR DOD COMPONENTS IN RESPONSE TO CORONAVIRUS DISEASE 2019. REF O IS ASD(MRA) MEMORANDUM, MILITARY PERSONNEL GUIDANCE FOR DOD COMPONENTS IN RESPONDING TO CORONAVIRUS DISEASE 2019. REF P IS ASD (MRA) MEMORANDUM, MILITARY PERSONNEL GUIDANCE (SUPPLEMENT 1) FOR DOD COMPONENTS IN RESPONDING TO CORONAVIRUS DISEASE 2019. REF Q IS THE JOINT TRAVEL REGULATIONS. REF R IS FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 16) REVISION 1 – DEPARTMENT OF DEFENSE GUIDANCE FOR DEPLOYMENT AND REDEPLOYMENT OF INDIVIDUALS AND UNITS DURING THE CORONAVIRUS DISEASE 2019 PANDEMIC. REF S IS MARINE CORPS ORDER 12271.1, TELEWORK FOR CIVILIAN MARINES. REF T IS MARADMIN 092/21, FY21 HARDSHIP DUTY PAY TEMPO PROGRAM DETAILS. REF U IS FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 18) – DEPARTMENT OF DEFENSE GUIDANCE FOR PROTECTING PERSONNEL IN DEPARTMENT OF DEFENSE WORKPLACES DURING THE CORONAVIRUS DISEASE 2019 PANDEMIC. REF V IS FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 11) – DEPARTMENT OF DEFENSE GUIDANCE FOR CORONAVIRUS DISEASE 2019 SURVEILLANCE AND SCREENING WITH TESTING. REF W IS FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 15) REVISION 1 – DEPARTMENT OF DEFENSE GUIDANCE FOR CORONAVIRUS DISEASE 2019 LABORATORY TESTING SERVICES. REF X IS DOD CORONAVIRUS TASK FORCE DIAGNOSTICS AND TESTING LEAD MEMORANDUM, OPTIMIZATION OF CORONAVIRUS DISEASE 2019 (COVID-19) TESTING RESOURCES. REF Y IS FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 17) – DEPARTMENT OF DEFENSE GUIDANCE FOR THE USE OF MASKS, PERSONAL PROTECTIVE EQUIPMENT, AND NON-PHARMACEUTICAL INTERVENTIONS DURING THE CORONAVIRUS DISEASE 2019 PANDEMIC. REF Z IS MARADMIN 182/21, U.S. MARINE CORPS GUIDANCE FOR DEPLOYMENT AND REDEPLOYMENT OF INDIVIDUALS AND UNITS TESTING DURING THE NOVEL CORONAVIRUS DISEASE 2019 (COVID-19) PANDEMIC.//
POC/The POCs LISTED IN THIS MARADMIN SHALL BE USED ONLY AFTER A MEMBER'S CHAIN OF COMMAND HAS BEEN UNABLE TO ASSIST.//
GENTEXT/REMARKS/1. Purpose. This MARADMIN:
1.a. Implements refs (a) and (c), and rescinds and replaces refs (e)-(i).
1.b. Should be read in its entirety, and in conjunction with refs (a) and (c), which are centrally located at www.defense.gov/Explore/Spotlight/Coronavirus/Latest-DOD-Guidance.
1.c. Provides clarifying guidance to aspects of refs (a) and (c). Commanders and supervisors will ensure that personnel traveling for purposes other than deployment review these references, along with the 2019 Novel Coronavirus (COVID-19) clarifying guidance provided in this MARADMIN. Guidance specific to the deployment and redeployment of individuals and units during the COVID-19 pandemic is located in refs (r) and (z). The clarifying guidance provided in this MARADMIN does not supersede the references and is organized by topic:
1.c.1. Paragraph 2 – clarifying guidance - personnel movement and travel restrictions.
1.c.1.b. Reporting conditions for unrestricted travel.
1.c.1.e. Leave travel for Marines.
1.c.1.f. Permanent change of station (PCS) orders.
1.c.2. Paragraph 3 – clarifying guidance - force health protection (FHP).
1.c.2.b. Travel screening and risk assessments.
1.c.2.c. Testing requirements.
1.c.2.d. Restriction of movement (ROM).
1.c.2.e. Specific travel guidance by type of travel.
1.c.3. Paragraph 4 – COVID-19 Manpower Tracking Application.
1.c.4. Paragraph 5 – Pay and allowances.
2. Clarifying Guidance - Personnel Movement and Travel Restrictions
2.a. Introduction. Per refs (a) and (b), official travel to or from restricted locations remains prohibited unless authorized by an exemption or approved waiver in accordance with ref (a). Ref (c) provides travel-related FHP policy; see paragraph 3 of this MARADMIN for FHP-related clarifying guidance.
2.a.1. Travel restriction guidance applies to all Government-funded travel, including Government-funded leave travel; temporary duty (TDY) travel; permanent duty travel, including PCS travel; reserve component (RC) travel for annual training (AT) and active duty for operational support (ADOS); and travel to Authorized and Ordered departures issued by the Department of State.
2.a.2. Travel restriction guidance applies to all Department of Defense (DoD) Service members, civilian employees, dependents of Service members, and personnel whose travel is Government-funded, whether traveling domestically or internationally.
2.a.3. All travelers whose travel is Government-funded must adhere to FHP guidance provided by refs (c) and (r), any applicable and subsequent force health protection guidance, and Centers for Disease Control and Prevention (CDC) guidance when traveling. See paragraph 3 of this MARADMIN.
2.b. Reporting Conditions for Unrestricted Travel
2.b.1. The status of travel restrictions is posted weekly on www.defense.gov/Explore/Spotlight/Coronavirus.
2.b.2. Pursuant to ref (b), DC, IL/MCICOM will coordinate Service-specific assessment and reporting requirements regarding installations, facilities, and locations, in accordance with ref (a).
2.c.1. Recruiting and Accession Activities
2.c.1.a. Marines within the entry level training pipeline (including enlisted and officer lateral moves) between basic training (e.g., Recruit Training and Officer Candidate School) and their first or subsequent (i.e., lateral move) permanent duty station (PDS) will continue movement to their PDS.
2.c.1.b. Officer students and officer commissioning program Marines in receipt of orders to The Basic School (TBS), schools, or universities will continue movement per their orders.
2.c.1.c. Marines in direct support of the accession supply chain will continue movement to their accession-related PDS. These Marines are Recruiters and Marines assigned to Marine Corps Recruiting Command, Drill Instructors and Marines assigned to the Marine Corps Recruit Training Regiments, and the instructors and staff at the Schools of Infantry, Officer Candidate School, TBS, and Formal Learning Centers.
2.c.1.d. DC MRA (MPP) will notify ASN(MRA) prior to reducing or suspending recruiting, accessions, basic training, or advanced individual training.
2.c.2. Travel for Global Force Management (GFM) Activities. Travel to execute operations, activities, and investments or Service-related training will continue to be coordinated between DC PPO, the Combatant Command, and the Joint Staff. In accordance with current policy guidance, specific GFM activities will be handled through normal GFM processes and procedures in coordination with DC PPO (PO/POC/F). See ref (r) for further deployment and re-deployment guidance.
2.c.3. Presidential Support Duties. Per ref (n), travel restrictions do not apply to DoD personnel and units:
2.c.3.a. Performing Presidential support duties as determined by the Director, White House Military Office.
2.c.3.b. Providing support to the U.S. Secret Service in accordance with the Presidential Protection Assistance Act of 1976 and DoD Directive 3025.13.
2.c.4. Travel to and from Professional Military Education (PME) programs.
2.d. Waivers. Pursuant to refs (a) and (b), the authority to approve travel restriction waivers, in accordance with ref (a), is delegated to an appropriate military officer in the grade of O-6, or a civilian equivalent, in the traveler’s chain of command or supervision.
2.d.1. Waivers shall be executed on a case-by-case basis.
2.d.2. Waivers must be coordinated between the gaining and losing organizations.
2.d.3. Waivers previously approved remain valid.
2.d.4. Mission-essential travel refers to work that must be performed to ensure the continued operations of mission-essential functions, including positions that are deemed key and essential, as determined by the Secretary of the Navy (SECNAV).
2.e. Leave Travel for Marines
2.e.1. Ref (a) addresses two types of leave travel for Service members: Government-funded and non-Government-funded leave travel.
2.e.1.a. Government-funded leave travel is authorized leave outside the local area that involves the member being reimbursed for the leave travel; travel restrictions apply to Government-funded leave. For example: Funded Environmental Morale Leave (FEML) and Consecutive Overseas Tour (COT) leave. Since travel restrictions apply, then Government-funded leave travel to or from a location where travel restrictions have not been lifted remains limited to travelers who have a valid exemption or an approved waiver. Further, all Government-funded leave travel shall be reviewed for approval at a level no lower than the Marine’s unit commander (normally O-5 level) or equivalent. This approval authority cannot be delegated further.
2.e.1.b. Non-Government-funded leave travel is authorized leave outside the local area that does not involve the member being reimbursed for leave travel. This is the most common type of leave travel, and is exempt from travel restrictions. This type of leave travel includes leave travel in conjunction with PCS or TDY orders. This leave travel shall be reviewed for approval at a level no lower than the Marine’s unit commander (normally O-5 level) or equivalent. This approval authority cannot be delegated further.
2.e.2. Per ref (a), commanders will follow the procedures in ref (c) and any subsequent applicable FHP guidance for all Marines traveling on leave. Pursuant to ref (c), unit commanders must conduct a risk assessment of the health status and travel itinerary for each traveler prior to making any leave determination. See paragraph 3 of this MARADMIN.
2.e.3. Marines will comply with DoD, Federal, State, and local restrictions while in leave status, and will comply with current CDC guidance and ref (c) when traveling. See paragraph 3 of this MARADMIN.
2.e.4. In the event a Marine returns from leave and is subsequently diagnosed positive for COVID-19 by a competent medical authority, or ordered into a ROM status, commanders are obligated to report this information in accordance with refs (j) and (k).
2.e.5. Marines who served on active duty from 11 March 2020 through 30 September 2020, are authorized to accumulate annual leave in excess of 60 days (i.e., Special Leave Accrual (SLA)) as shown on the September 2020 Leave and Earnings Statement (LES). This SLA is specifically due to COVID-19 and does not include SLA for any other circumstances for which SLA may be authorized. When combined with other previously earned SLA and accrued annual leave, the total amount of leave carried over cannot exceed 120 days. The SLA earned during fiscal year 2020 specifically due to COVID-19 may be retained until the end of fiscal year 2023 (30 September 2023). Other SLA earned for circumstances other than COVID-19 is retained according to when and what circumstances it was earned following normal SLA procedures.
2.e.6. Commanders will continue to encourage Marines to use their leave, in a manner consistent with COVID-19-related policies and guidance, during the year it is earned.
2.f. Permanent Change of Station (PCS) Orders
2.f.1. DC MRA (MM/RA) will write PCS orders that presume favorable travel conditions at the time of execution, and will make amendments or modifications of orders if warranted. Marines traveling under an exemption or a waiver will execute orders as directed by DC MRA (MM/RA).
2.f.2. Upon approval of a PCS travel waiver, the commander will provide a copy to the Marine, and will forward a copy to DC MRA (MM) for active component Marines and to DC MRA (RA) for Active Reserve Marines.
2.f.3. Marines executing PCS orders are required to contact their gaining command in advance of their travel and provide their itinerary. Marines (and dependents if applicable) will be accounted for by the gaining command upon arrival in the vicinity of the new PDS. Gaining commands will direct the Marine (and dependents if applicable) into any ROM and post-travel reception required at their destination. The Marine (and dependents if applicable) will remain in a travel status (awaiting transportation) and will continue to be entitled to travel allowances incident to executing official travel per refs (o) – (q) and paragraph 5 of this MARADMIN. Remaining in a travel status during ROM performed at the destination is applicable to those members required to occupy commercial or government temporary lodging with a cost incurred. The Marine (and dependents, if applicable) will not be considered as having been joined to the command until the day following the last entire inclusive day where the ordered ROM facility was occupied. Upon completion of the required ROM period or effective date permanent type quarters become occupied, the local Installation Personnel Administration Center (IPAC)/reporting unit will join the member in order to start appropriate station allowances.
2.f.4. Gaining commands are authorized to modify the basic PCS order via the reporting endorsement when the ROM completion date exceeds the report not later than (NLT) date. Gaining commands will provide a reporting endorsement that includes the directed ROM period to the local IPAC/reporting unit.
2.f.5. Marines will be required to submit the following items to their Disbursing Officer/Finance Officer (DO/FO) for reimbursement:
2.f.5.a. DD Form 1351-2 travel claim;
2.f.5.b. All authorization letters to travel as applicable, and receipts for lodging incurred while in a ROM or Temporary Lodging Expense (TLE) status; and
2.f.5.c. The command endorsement directing ROM in the vicinity of the gaining PDS. This endorsement will include a modified report date that includes the completion of ROM, if applicable.
2.f.6. When practicable within operational requirements, commanders may initiate coordination with DC MRA (MM/RA) regarding in-place assignment extensions or the applicability of waivers for PCS moves for Marines with school-age dependents in order to minimize school year disruption and education costs.
2.g. Documentation. In all cases that a traveler is under an exemption or has been provided a waiver, commanders or supervisors will document this fact within a member’s travel orders.
3. Clarifying Guidance - Force Health Protection. Ref (c) provides detailed non-deployment-related pre- and post-travel guidance, including screening, risk assessments, testing, ROM, and quarantine guidance. The reference is organized by the traveler’s origin and destination (i.e., within or outside the United States); type of travel (i.e., official or unofficial); and person traveling (i.e., Marine, DoD family member, DoD civilian employee, or DoD contractor personnel), and should be reviewed by each traveler and applied as necessary to their particular circumstances. This paragraph provides clarifying guidance to aspects of ref (c).
3.a.1. All definitions for travel-related terms are located in ref (q). For the purposes of ref (c), the term “United States” means the 50 States, the District of Columbia, and U.S. Territories.
3.a.1.a. Quarantine. Separates and restricts the movement of people who were exposed to COVID-19, but are not COVID-19 positive and/or symptomatic, to prevent transmission to others.
3.a.1.b. Isolation. Separates sick or symptomatic people with COVID-19 from people who are not sick.
3.a.1.c. Close Contact. Per ref (c), a close contact is defined as being within six feet of an infected (i.e., COVID-19) person for a cumulative total of 15 minutes, or more, over a 24-hour period.
3.a.2. Pursuant to ref (d), the first General Officer or Senior Executive Service (GO/SES) in a member's chain of command may:
3.a.2.a. Implement more restrictive guidance and additional FHP measures based on mission requirements and local risk assessments, in consultation with their medical staffs and public health authorities.
3.a.2.b. Choose to exempt assigned aircrew and aircraft maintenance recovery team members on commercial, military contracted, and organic military aircraft from the guidance provided in ref (c), to the extent permissible, consistent with applicable legal requirements.
3.a.3. Travel that is limited to transit between and through foreign countries contained wholly within a single Geographic Combatant Command (GCC) area of responsibility, and between GCC areas of responsibility, is not subject to ref (c) and will be managed by each relevant GCC or GCCs as appropriate.
3.a.4. For travel from the United States to another country, traveler’s must follow all requirements in refs (a) and (c), including all requirements imposed by the GCC with responsibility over the destination geographic area, all applicable Host Nation (HN) procedures, and all requirements of the Electronic Foreign Clearance Guide (EFCG).
3.a.5. During all travel, travelers will continue to adhere to public health measures in accordance with ref (y), such as physical distancing to the greatest extent possible and mask wearing.
3.b. Travel Screening and Risk Assessments
3.b.1. The appropriate commander or supervisor, assisted by medical personnel, must complete a risk assessment in accordance with ref (c) for each type of traveler:
3.b.1.a.1. Required before all travel.
3.b.1.a.2. Required upon arrival in the United States for all travel from or through a foreign country to the United States.
3.b.1.b. DoD Civilian Employees. Required before official travel.
3.b.1.c. DoD Contractor Personnel. Required before official travel outside the United States.
3.b.1.d. DoD Family Members. Reimbursement for official travel may only occur after the Marine certifies, to the best of his or her knowledge, that family members have completed a risk assessment.
3.b.1.d.1. Prior to family members traveling on official orders, the Marine must attest that all family members traveling have adhered to the same pre-travel requirements as set forth for Service members in ref (c), along with having completed a risk assessment of the health status and itinerary. Failure to do so may result in a delay or cancellation of previously authorized travel.
3.b.1.d.2. Commands will ensure the attestation is completed and signed within 14 days of travel. A sample attestation memo is located on the DC MRA portal, www.manpower.usmc.mil/webcenter/portal/Secretariat.
3.b.1.d.3. Commands will provide the local IPAC a copy to incorporate into the travel orders issued to the Marine, and ensure the Marine retains a copy of the attestation in order to facilitate reimbursement of travel expenses.
3.b.2. The risk assessment of the health status of the traveler will determine, at a minimum:
3.b.2.a. Whether the individual is familiar with how to self-monitor and what actions to take if he or she develops COVID-19 symptoms or contracts COVID-19.
3.b.2.b. Whether the individual has exhibited any signs or symptoms of COVID-19 within the previous 14 days.
3.b.2.c. Whether the individual has had contact with anyone having, or known to have exhibited, signs or symptoms of COVID-19, or who has tested positive for COVID-19 within the previous 14 days.
3.b.2.d. Whether the individual has recently recovered from COVID-19 and, if so, when and if they have documentation of a positive viral test and documentation of recovery from a healthcare provider.
3.b.2.e. Whether the individual has completed a COVID-19 immunization series and, if so, when.
3.b.2.f. Whether the individual has traveled to a country, State, territory, county, or city with high or increasing COVID-19 transmission as defined by the CDC within the previous 14 days.
3.b.2.g. Whether the individual is at increased risk of severe illness of COVID-19.
3.b.2.h. The status of community spread of COVID-19 for the travel destination.
3.b.3. In all cases, travelers should not travel if they have tested positive for COVID-19 and have not yet met the criteria for discontinuing isolation, they are symptomatic, or they are pending COVID-19 test results. Travel should also be delayed if, in the past 14 days, an individual has been in close contact with someone who has tested positive for and/or been symptomatic of COVID-19 and requires self-quarantine, unless exempted based on a full recovery of prior COVID-19 infection or prior completion of COVID-19 vaccination, per ref (w), and that the traveler remains symptom-free.
3.b.4. The appropriate leader or supervisor shall educate each traveler on how to self-monitor and what actions to take if one develops COVID-19 signs or symptoms or contracts COVID-19.
3.b.5. For travel via military airlift (contracted or organic), Aerial Point of Debarkation/Embarkation (APOE) health screening in accordance with ref (c) is mandatory. Travelers who have a medical issue identified during screening, or who refuse to be tested or screened at the APOE, may be denied travel.
3.c. Testing Requirements. Testing refers to tests that utilize molecular or, in certain limited circumstances, antigen testing methods, in accordance with ref (x). For DoD testing guidelines, refer to ref (l), and refs (v)-(x). Ref (c) deleted the previously authorized waiver of pre-travel testing for air travel (i.e., paragraph 7.b. of ref (i)). If the destination location requires a specific test or stricter test timing, travelers must follow the destination location requirement instead; this may include the EFCG.
3.c.1. Personnel conducting official international air travel from the United States to a foreign country, will be tested with a viral test conducted during the three days prior to departure of the commercial or military airlift and maintain proof of the negative test during travel.
3.c.1.a. Exceptions. Unless otherwise required by a more restrictive DoD policy:
3.c.1.a.1. Individuals fully recovered from a laboratory-confirmed diagnosis of COVID-19 infection within the previous 90 days are not required to undergo viral testing. Individuals recovered from COVID-19 infection and desiring to travel will receive clearance from a healthcare provider or public health official and maintain a copy of the clearance letter in their possession during travel.
3.c.1.a.2. Individuals who are 14 days post-completion of COVID-19 vaccination with a Food and Drug Administration (FDA)-authorized vaccine and meet all of the CDC criteria for the specific vaccine administered, are not required to undergo viral testing prior to travel from the United States to a foreign country.
3.c.1.a.3. Patients and their attendants in the enroute care system may be exempted by the Theater Validating Flight Surgeon until they arrive at their final treatment destination.
3.c.1.b. Testing is authorized on presentation of an electronic or paper copy of orders at military medical treatment facilities in accordance with refs (c) and (l).
3.c.1.c. Active Duty Service members are authorized to receive travel-related testing in accordance with ref (l) and applicable Department of the Navy (DoN) guidance.
3.c.2. Personnel conducting international air travel from a foreign country to the United States, are required to be tested with a viral test conducted during the three days prior to departure of the commercial or military flight and three to five days after completion of travel. For military flights, personnel will follow this guidance unless operational circumstances cannot accommodate.
3.c.2.a. Exceptions. All personnel (with the exceptions noted below) flying from a foreign country to the United States must be tested both before and after travel.
3.c.2.a.1. Unless otherwise required by a more restrictive DoD policy, individuals fully recovered from a laboratory-confirmed diagnosis of COVID-19 infection within the previous 90 days are not required to undergo viral testing. Individuals recovered from COVID-19 infection and desiring to travel will receive clearance from a healthcare provider or public health official and maintain a copy of the clearance letter in their possession during travel.
3.c.2.a.2. Patients and their attendants in the enroute care system may be exempted from testing by the Theater Validating Flight Surgeon until they arrive at their final treatment destination.
3.c.2.b. Testing is authorized on presentation of an electronic or paper copy of orders at military medical treatment facilities in accordance with refs (c) and (l).
3.c.2.c. Active Duty Service members are authorized to receive pre-travel testing in accordance with ref (x) and applicable DoN guidance.
3.c.2.d. Pre-travel, post-travel, and ROM-associated COVID-19 testing is authorized for official international air travel at military medical treatment facilities on a non-reimbursable basis in accordance with ref (m) for DoD civilian employees and members of the Selected Reserve not otherwise eligible to receive care.
3.d. Restriction of Movement (ROM). During any required travel-associated ROM period, travelers will strictly adhere to ROM guidelines provided in the “Steps to Be Taken During ROM” section of ref (c). Travelers must follow all requirements imposed by the GCC with responsibility over the destination geographic area, all applicable HN procedures, and all requirements of the EFCG in a manner consistent with existing agreements or arrangements if HN requirements are more stringent.
3.d.1. Per ref (d), only ROM is required, either before travel or after arrival.
3.d.2. If ROM is conducted prior to travel, travel to and from an APOE following ROM completion will, to the maximum extent possible, be conducted in a manner that minimizes the risk of personnel being exposed to or contracting COVID-19 during travel.
3.d.3. ROM after arrival at the travel destination may not be required by the destination health authority if travelers have undergone COVID-19 testing prior to travel. Travelers should check with GCCs, State and local public health authorities, and military installations for current requirements.
3.d.4. Exemptions to ROM. Individual exempt from ROM will continue to adhere to public health measures, such as physical distancing to the greatest extent possible and mask wearing, in accordance with ref (y).
3.d.4.a. Patients and their attendants in the enroute care system are exempt from ROM requirements. Medical care will not be delayed due to ROM requirements.
3.d.4.b. Unless otherwise required by a more restrictive DoD policy, pre- and post-travel ROM is not required for individuals who are 14 days post-completion of COVID-19 vaccination with a FDA-authorized vaccine and meet all of the CDC criteria for the specific vaccine administered.
3.d.4.c. Per ref (d), individuals fully recovered from a laboratory-confirmed diagnosis of COVID-19 infection within the previous 90 days, are not required to be ROM as long as they are symptom free.
3.d.5. Authority to Decrease ROM. Per ref (d), after an appropriate risk assessment, the first GO/SES in a member’s chain of command may decrease a 14-day ROM period to a ROM of 10 days without testing; or to a ROM of seven days with a negative test drawn within 48 hours of the end of the 7-day ROM period.
3.d.6. Waivers of ROM. SECNAV may waive ROM requirements for Marines, conducting official travel from or through a foreign country to the United States, on a case-by-case basis, with an appropriate risk assessment and mitigation measures. Requests will be routed to SECNAV via DC PP&O (Marine Corps COVID Cell (MCCC)).
3.d.7. Commanders are authorized to allow Marines to work from home within the criteria applied to civilian employees approved to telework under ref (s).
3.d.8. Travelers whose supervisors require them to return to the workplace for mission essential business prior to the end of a required ROM period must meet the applicable requirements in ref (u).
3.d.9. RC Marines on official travel will complete any required health and ROM measures, including home-based quarantine or self-isolation if required, prior to the end of the official duty period.
3.e. Specific Travel Guidance by Type of Travel
3.e.1. Travel from the United States to a Foreign Country
3.e.1.a. Official Travel
3.e.1.a.1.a. Will complete travel screening and risk assessment requirements (see paragraph 3.b.).
3.e.1.a.1.b. Will complete testing requirements (see paragraph 3.c.).
3.e.1.a.1.c. Upon arrival at the foreign country destination, will observe applicable HN public health measures, and ROM for 14 days. If it is necessary to undertake a pre-arrival ROM to observe applicable HN public health measures, the Marine will ROM for 14 days (see paragraph 3.d.).
3.e.1.a.2. DoD Family Members. Marines must attest that, to the best of their knowledge, their family members have followed the same requirements as set forth in paragraph 3.e.1.a.1. Failure to do so may result in delay or cancellation of previously authorized travel (see paragraph 3.b.1.d.).
3.e.1.a.3. DoD Civilian Employees. Will follow the same requirements as set forth in paragraph 3.e.1.a.1.
3.e.1.a.4. DoD Contractor Personnel. DoD contracting officers will ensure that all contracts that include performance outside the United States require DoD contractor personnel to comply with the country entry requirements of the respective GCC (which may include screening, ROM, and testing), as reflected in the EFCG, and all applicable HN procedures. The GCC may waive such additional requirements, consistent with existing authorities.
3.e.1.b. Unofficial Travel
3.e.1.b.1. Per ref (d), Marines must follow all requirements imposed by the GCC with responsibility over the destination geographic area, all applicable HN procedures, and all requirements of the EFCG.
3.e.1.b.2. DoD family members, DoD civilian employees, and DoD contractor personnel should comply with the guidance and/or applicable HN procedures for the areas to which, and through which, they are traveling, and are strongly recommended to follow the FHP guidance provided within ref (c) and this MARADMIN.
3.e.2. Travel From or Through a Foreign Country to the United States
3.e.2.a. Official Travel
3.e.2.a.1.a. Prior to departure, will conduct pre-travel screening, and testing (see paragraphs 3.b. and 3.c.). If COVID-19 infection is indicated, delay travel and consult a healthcare provider for clearance to travel.
3.e.2.a.1.b. Upon arrival in the United States, will conduct a risk assessment (see paragraph 3.b.). Travelers who become ill or have had close contact with a person known to have COVID-19 during travel must self-isolate (if COVID-19 positive and/or symptomatic) or quarantine (if exposed but not COVID-19 positive and/or symptomatic) and notify their chain of command or supervisor.
3.e.2.a.1.b.1. Exception to quarantine: Travelers fully recovered from a laboratory-confirmed diagnosis of COVID-19 infection within the previous 90 days, or those who are fully vaccinated (i.e., 14-days post-completion of COVID-19 vaccination with a FDA-authorized vaccine and meet all of the CDC criteria for the specific vaccine administered), are not required to quarantine as long as they remain symptom-free.
3.e.2.a.1.c. Upon arrival at his or her destination domicile:
3.e.2.a.1.c.1. Will ROM for 14 days (see paragraph 3.d.).
3.e.2.a.1.c.2. Will be tested, between 3 and 5 days after arrival, for COVID-19 in accordance with CDC guidance (see paragraph 3.c.2.).
3.e.2.a.1.c.3. Will comply with all installation, CDC, State, and local government guidance.
3.e.2.a.2. DoD Family Members, DoD Civilian Employees, and DoD Contractor Personnel
3.e.2.a.2.a. Will conduct pre-travel screening and testing as outlined in paragraph 3.e.2.a.1.a.
3.e.2.a.2.b. Are strongly recommended to follow the guidance provided in paragraphs 3.e.2.a.1.b. and 3.e.2.a.1.c.
3.e.2.b. Unofficial Travel
3.e.2.b.1.a. During travel from or through a foreign country, will comply with all guidance and/or procedures imposed by the GCC with responsibility over the particular geographic area, all applicable HN procedures, and all requirements of the EFCG.
3.e.2.b.1.b. Prior to departure, will conduct pre-travel screening and risk assessment procedures (see paragraph 3.b.). If COVID-19 infection is indicated, delay travel and consult a healthcare provider for clearance to travel.
3.e.2.b.1.c. Upon arrival at his or her destination in the United States:
3.e.2.b.1.c.1. Will conduct a risk assessment (see paragraph 3.b.). Travelers who become ill or have had close contact with a person known to have COVID-19 during travel must self-isolate (if COVID-19 positive and/or symptomatic) or quarantine (if exposed but not COVID-19 positive and/or symptomatic) and notify their chain of command or supervisor. Exception to quarantine: Travelers fully recovered from a laboratory-confirmed diagnosis of COVID-19 infection within the previous 90 days, or those who are fully vaccinated (i.e., 14-days post-completion of COVID-19 vaccination with a FDA-authorized vaccine and meet all of the CDC criteria for the specific vaccine administered), are not required to quarantine as long as they remain symptom-free.
3.e.2.b.1.c.2. Will ROM for 14 days (see paragraph 3.d.).
3.e.2.b.2. DoD Family Members, DoD Civilian Employees, and DoD Contractor Personnel. Are strongly recommended to follow the guidance provided in paragraph 3.e.2.b.1.
3.e.3. Travel Within the United States
3.e.3.a. Official Travel
3.e.3.a.1.a. May conduct unrestricted travel between installations that meet the criteria set forth in ref (a) (see paragraph 2 of this MARADMIN).
3.e.3.a.1.b. Will comply with military installation, State, and local government travel restrictions.
3.e.3.a.1.c. Should review and consider CDC guidance.
3.e.3.a.1.d. Will conduct pre-travel screening (see paragraph 3.b.) and comply with DoN-specific guidance and/or procedures for ROM, and testing. Pursuant to ref (d):
3.e.3.a.1.d.1. The first GO/SES in a member's chain of command may:
3.e.3.a.1.d.1.a. Implement more restrictive FHP guidance and additional FHP measures based on mission requirements and local risk assessments, in consultation with their medical staffs and public health authorities.
3.e.3.a.1.d.1.b. Choose to exempt assigned aircrew and aircraft maintenance recovery team members on commercial, military contracted, and organic military aircraft from the FHP guidance provided in ref (c), to the extent permissible, consistent with applicable legal requirements.
3.e.3.a.1.d.2. In instances that a viral test is required, individuals fully recovered from a laboratory-confirmed diagnosis of COVID-19 infection within the previous 90 days are not required to undergo any required viral testing, as long as they are symptom free. Required testing is authorized in accordance with ref (x).
3.e.3.a.1.d.3. In instances that one or more travel-related ROM periods is required, exemptions are addressed in paragraph 3.d.
3.e.3.a.1.d.4. In instances that a viral test and/or travel-related ROM is required, patients and their attendants in the enroute care system are exempt from ROM requirements and may be exempted from testing by the Validating Flight Surgeon until they arrive at their final treatment destination. Medical care will not be delayed due to any ROM requirements.
3.e.3.a.2. DoD Family Members. Are strongly recommended to follow the guidance provided in paragraph 3.e.3.a.1.
3.e.3.a.3. DoD Civilian Employees and DoD Contractor Personnel. Will conduct pre-travel screening (see paragraph 3.b.) and are strongly recommended to follow the guidance provided in paragraph 3.e.3.a.1.
3.e.3.b. Unofficial Travel
3.e.3.b.1.a. Should consult the COVID-19 Travel Restrictions Installation Status Update (see paragraph 2.b.1.).
3.e.3.b.1.b. Will comply with military installation, State, and local government travel restrictions.
3.e.3.b.1.c. Will comply with CDC guidance as well as the guidance and procedures provided in paragraph 3.e.3.a.1.d.
3.e.3.b.2. DoD Family Members, DoD Civilian Employees, and DoD Contractor Personnel. Are strongly recommended to follow the guidance provided in paragraph 3.e.3.b.1.
4. COVID-19 Manpower Tracking Application. Per ref (k), a COVID-19 Manpower Tracking Application enables commanders and supporting staff to report the personnel status of Marines, Sailors, civilian employees, contractors, dependents, and other Service personnel impacted by COVID-19. To ensure the accurate categorization of personnel, commanders and supporting staff shall review the reference and, if necessary, request assistance from the DC MRA (Secretariat).
5. Pay and Allowances. DoD has provided supplemental military personnel guidance in responding to COVID-19 in refs (o) and (p) that is posted at: www.defense.gov/Explore/Spotlight/Coronavirus. This supplemental guidance is intended for use by commanders to identify military personnel policies, pay, benefits, and flexibilities to help mitigate risk to personnel and their families, respond to evolving situations, and ensure the readiness of our force. Commanders must review this guidance, and make every effort to ensure there is no duplication of payments relative to the authorities discussed, other than those specifically authorized by refs (o) and (p) (e.g., concurrent receipt of Basic Allowance for Subsistence (BAS) and government provided meals at no cost). Most pay and benefits for Marines continue and are unaffected by the effects of COVID-19, and, unless addressed by supplemental guidance, will continue to be paid in accordance with existing laws, regulations, policies, and procedures. Further clarifying guidance is provided below:
5.a. The following may apply while in a travel status:
5.a.1. Per Diem for those ordered into isolation by a competent authority.
5.a.2. Temporary Lodging Expense (TLE).
5.a.3. Temporary Lodging Allowance (TLA).
5.a.4. Family Separation Allowance (FSA).
5.a.4.a. FSA-T is not authorized for a Marine when their dependent(s) and/or Service member spouse resides in the area of the Marine's temporary duty location.
5.a.4.b. FSA-S is now authorized to begin accruing for members, with dependents, embarked aboard a ship while at the homeport. FSA will not be authorized when the status aboard ship does not remain for greater than 30 days, or when the requirement to remain aboard a ship at homeport is for disciplinary reasons.
5.a.5. Hardship Duty Pay–Tempo (HDP-T). Units and/or individual Marines who are required to conduct training enroute to an operational deployment after 11 December 2020 and before 1 October 2021 are encouraged to review ref (t) for additional HDP-T guidance.
5.b. The following may apply while in a non-travel status:
5.b.1. FSA-R is not authorized for a Marine when their dependent(s) and/or Service member spouse resides in the area of the Marine's permanent duty location.
5.b.2. Hardship Duty Pay – Restriction of Movement (HDP-ROM).
5.b.3. Concurrent receipt of BAS and government provided meals at no cost.
5.b.4. Special authorization of BAS at the BAS II rate.
5.b.5. Family Separation Housing-BAH Based Location (FSH-B).
5.b.6. Family Separation Housing-OHA Based Location (FSH-O).
5.b.7. Continuation of Hazardous Duty Incentive Pay and Aviation Incentive Pay.
5.c. Marines can only receive FSH-B or FSH-O, but not both for the same period of service.
5.d. Commanders who authorize HDP-ROM or BAS-II for a Marine under the authorities listed in refs (o) and (p) must submit a copy of the written order directing the Marine into a ROM to the appropriate IPAC or unit administrator indicating the authorizations for that Marine along with justifications. BAS II is only for enlisted Marines. Officers must not be authorized BAS II.
5.d.1. In instances in which expenses by the Marine are to be reimbursed (e.g., HDP-ROM) the Marine’s lodging receipt must be submitted. In the case of HDP-ROM, the lodging receipt will be utilized solely to establish the number of days of eligibility for reimbursement, as HDP-ROM is a flat rate pay of $100 per day, not to exceed $1,500 per month. The rate of $100 per day may not be supplemented and there is no provision to authorize a waiver for lodging costs exceeding the HDP-ROM rate payable.
5.d.2. In instances in which BAS II is approved, the commander must indicate the start and end date of that approval, whether the Marine was required to consume from a commercial source, and whether the Marine’s quarters was equipped with adequate food storage and meal preparation facilities. If adequate food storage and preparation facilities are present, BAS II must not be authorized.
5.d.3. Commanders already have reporting capability for FSA, FSH-B, FSH-O, and BAS. No NAVMC 11116 is required.
5.d.4. Commanders do not have reporting capability for TLA or TLE. NAVMC 11116 is the request for DO/FO for TLA. TLE is paid as a travel entitlement with the DD 1351-2.
5.e. Use of the Government Travel Charge Card (GTCC) is authorized for lodging within the vicinity of the PDS incident to HDP-ROM. This does not include meals. Marines will make every effort to keep costs below the daily threshold of $100 and are responsible for paying the statement balance in full upon receipt. Marines who are authorized HDP-ROM and intend to use the GTCC for lodging should notify the unit's Agency Program Coordinator. The rate of $100 per day may not be supplemented and there is no provision to authorize a waiver for lodging costs exceeding the HDP-ROM rate payable.
5.f. Marines who are ordered into ROM due to exposure or suspected exposure of COVID-19, to protect the health of others, or to assure essential mission function, and housed in the barracks, shall not be charged for government meals and shall receive BAS without deduction for the duration of the order into ROM. Marines will continue to receive their BAH in effect prior to being ordered into said ROM. Commanders must submit a copy of the written order directing the Marines into ROM with the start and end dates to the appropriate IPAC or unit administrator. All meals from the mess halls will continue to be issued using the CAC EDIPI as the source document.
5.g. Additional procedural guidance for disbursing and finance personnel will be provided via Pay and Allowance Advisory Notices (PAAN) obtainable at: www.manpower.usmc.mil/webcenter/portal/Finance.
5.h. Additional procedural guidance for administrative personnel will be provided via Personnel Administrative Advisories (PAA) obtainable at: eis.usmc.mil/sites/missa/SitePages/paa.aspx.
6. Points of Contact
6.a. DC MRA, Manpower Military Personnel Policy: email@example.com.
6.b. DC MRA, Active Duty Military Manpower Management: firstname.lastname@example.org.
6.c. DC MRA, Active Reserve and Selected Reserve Marines: email@example.com and firstname.lastname@example.org.
6.d. DC MRA, Secretariat/Manpower Information: email@example.com.
6.e. DC MRA, Civilian Employees: firstname.lastname@example.org; email@example.com.
6.f. DC AVN: firstname.lastname@example.org.
6.g. DC IL: email@example.com; firstname.lastname@example.org.
6.h. DC PPO, Marine Corps COVID Cell (MCCC): email@example.com; firstname.lastname@example.org.
6.i. DC PR (RFF): email@example.com; hqmc_P_R_RFF@usmc.mil.
6.j. HQMC Health Services: firstname.lastname@example.org; email@example.com.
7. This MARADMIN applies to the Total Force.
8. This MARADMIN has been coordinated with DC AVN, DC IL, DC PPO, DC PR, and Health Services, and approved for release by LtGen David A. Ottignon, Deputy Commandant for Manpower and Reserve Affairs.//